Atlas Trials

Arginase Inhibition in Type 1 and Type 2 Diabetes Mellitus

Clinical trial NCT05806502 · COMPLETED

Trial details

NCT number
NCT05806502
Sponsor
Karolinska Institutet
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 1 DiabetesType 2 Diabetes
Start date
2018-11-01
Primary completion
2023-04-30
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.